Showing results (491-500 of 622) with videos related to

Sort By:
Pageof 63
Breast Cancer Research : BCR|November 7, 2013
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisBella Pajares, Marina Pollán, Miguel Martín, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 31, 2008
Cardiogenic shock in acute coronary syndrome in the Spanish populationManuel Ruiz Bailén, Luis Rucabado-Aguilar, Ana María Castillo-Rivera, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Rule-out test for autism using machine-learning analysis of molecular temporal dynamics in hair - a multicenter studyVishal Midya, Ghalib A Bello, Louis A Gomez, et al.
Emerging Infectious Diseases|June 25, 2025
Borrelia Lineages Adjacent to Zoonotic Clades in Black Flying Foxes (Pteropus alecto), Australia, 2018-2020Taylor B Verrett, Caylee A Falvo, Evelyn Benson, et al.
Journal of Clinical and Translational Research|April 10, 2023
Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infectionAnabel Franco-Moreno, David Brown-Lavalle, Nicolás Rodríguez-Ramírez, et al.
Breast Cancer Research and Treatment|February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyMiguel Martin, Jan C Brase, Amparo Ruiz, et al.
Oncotarget|July 5, 2022
Role of germline variants in the metastasis of breast carcinomasÁngela Santonja, Aurelio A Moya-García, Nuria Ribelles, et al.
Clinical Breast Cancer|July 25, 2008
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancerJuan Lucas Bayo-Calero, José I Mayordomo, Pedro Sánchez-Rovira, et al.
Briefings in Bioinformatics|February 13, 2026
ChemEmbed: a deep learning framework for metabolite identification using enhanced MS/MS data and multidimensional molecular embeddingsMuhammad Faizan-Khan, Roger Giné, Josep M Badia, et al.
The Lancet. Oncology|April 1, 2021
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative studyHope S Rugo, Florence Lerebours, Eva Ciruelos, et al.
Pageof 63